Apyx Medical Corporation APYX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 58.42M | 55.90M | 52.84M | 47.90M | 46.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 58.42M | 55.90M | 52.84M | 47.90M | 46.51M |
| Cost of Revenue | 21.32M | 20.60M | 19.80M | 17.89M | 17.85M |
| Gross Profit | 37.09M | 35.30M | 33.04M | 30.01M | 28.67M |
| SG&A Expenses | 37.33M | 36.28M | 36.12M | 35.97M | 37.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 61.95M | 60.21M | 59.29M | 57.41M | 58.82M |
| Operating Income | -3.54M | -4.31M | -6.45M | -9.51M | -12.31M |
| Income Before Tax | -7.97M | -8.71M | -10.84M | -14.26M | -17.05M |
| Income Tax Expenses | 439.00K | 364.00K | 270.00K | 265.00K | 247.00K |
| Earnings from Continuing Operations | -8.41 | -9.08 | -11.11 | -14.52 | -17.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -224.00K | -93.00K | -106.00K | -16.00K | 34.00K |
| Net Income | -8.63M | -9.17M | -11.21M | -14.54M | -17.26M |
| EBIT | -3.54M | -4.31M | -6.45M | -9.51M | -12.31M |
| EBITDA | -2.76M | -3.59M | -5.79M | -8.93M | -11.75M |
| EPS Basic | -0.20 | -0.22 | -0.27 | -0.36 | -0.45 |
| Normalized Basic EPS | -0.12 | -0.13 | -0.17 | -0.22 | -0.28 |
| EPS Diluted | -0.20 | -0.22 | -0.27 | -0.36 | -0.45 |
| Normalized Diluted EPS | -0.12 | -0.13 | -0.17 | -0.22 | -0.28 |
| Average Basic Shares Outstanding | 170.50M | 167.38M | 164.37M | 160.42M | 154.32M |
| Average Diluted Shares Outstanding | 170.50M | 167.38M | 164.37M | 160.42M | 154.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |